MarketWire Corrects Erroneous Arena Pharma (ARNA) Release
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Join SI Premium – FREE
Arena Pharmaceuticals (Nasdaq: ARNA) shares are grabbing attention following a correction issued on a press release. According to MarketWire, a news release earlier today on behalf of Arena Pharmaceuticals, Inc. in error entitled, "Arena Pharmaceuticals Awaits FDA Advisory Committee Meeting".
This release was issued without the approval of Arena Pharmaceuticals, Inc.
This release was issued without the approval of Arena Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sky Quarry names Heidi Bowman as CFO
- OSR Health faces Nasdaq delisting, plans appeal and $15M put option
- Nvidia makes minority investment in Cloverleaf Infrastructure
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
